272 related articles for article (PubMed ID: 33901013)
1. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
[TBL] [Abstract][Full Text] [Related]
2. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells.
Zeng C; Xu Y; Xu L; Yu X; Cheng J; Yang L; Chen S; Li Y
BMC Cancer; 2014 Sep; 14():693. PubMed ID: 25245097
[TBL] [Abstract][Full Text] [Related]
4. C/EBPβ contributes to transcriptional activation of long non-coding RNA NEAT1 during APL cell differentiation.
Wang Y; Fu L; Sun A; Tang D; Xu Y; Li Z; Chen M; Zhang G
Biochem Biophys Res Commun; 2018 May; 499(2):99-104. PubMed ID: 29111326
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.
Truong BT; Lee YJ; Lodie TA; Park DJ; Perrotti D; Watanabe N; Koeffler HP; Nakajima H; Tenen DG; Kogan SC
Blood; 2003 Feb; 101(3):1141-8. PubMed ID: 12393450
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
[TBL] [Abstract][Full Text] [Related]
7. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
8. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
Duprez E; Wagner K; Koch H; Tenen DG
EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
[TBL] [Abstract][Full Text] [Related]
9. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
10. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.
Imaizumi M; Suzuki H; Yoshinari M; Sato A; Saito T; Sugawara A; Tsuchiya S; Hatae Y; Fujimoto T; Kakizuka A; Konno T; Iinuma K
Blood; 1998 Jul; 92(2):374-82. PubMed ID: 9657734
[TBL] [Abstract][Full Text] [Related]
12. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.
Kitareewan S; Pitha-Rowe I; Sekula D; Lowrey CH; Nemeth MJ; Golub TR; Freemantle SJ; Dmitrovsky E
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3806-11. PubMed ID: 11891284
[TBL] [Abstract][Full Text] [Related]
13. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
Jing Y; Xia L; Lu M; Waxman S
Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities.
Lee YJ; Jones LC; Timchenko NA; Perrotti D; Tenen DG; Kogan SC
Blood; 2006 Oct; 108(7):2416-9. PubMed ID: 16788101
[TBL] [Abstract][Full Text] [Related]
15. ATPR induces acute promyelocytic leukemia cells differentiation and cycle arrest via the lncRNA CONCR/DDX11/PML-RARα signaling axis.
Liu S; Zhan W; He X; Hao M; Shen W; Zhang X; Wang M; Li Z; Hou R; Ou Z; Feng Y; Chen F
Gene; 2024 Jul; 917():148443. PubMed ID: 38582263
[TBL] [Abstract][Full Text] [Related]
16. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
[TBL] [Abstract][Full Text] [Related]
17. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
Nervi C; Ferrara FF; Fanelli M; Rippo MR; Tomassini B; Ferrucci PF; Ruthardt M; Gelmetti V; Gambacorti-Passerini C; Diverio D; Grignani F; Pelicci PG; Testi R
Blood; 1998 Oct; 92(7):2244-51. PubMed ID: 9746761
[TBL] [Abstract][Full Text] [Related]
18. A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.
Tan Y; Wang X; Song H; Zhang Y; Zhang R; Li S; Jin W; Chen S; Fang H; Chen Z; Wang K
Blood; 2021 Mar; 137(11):1503-1516. PubMed ID: 32854112
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E
Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
